Nuvation Bio Inc. (NUVB)

Nuvation Bio Revenue

Nuvation Bio had revenue of $31.69M in the quarter ending June 30, 2026, with 555.64% growth. This brings the company's total for the last twelve months to $169.90M, up 1,083.56% year-over-year. In the year 2025, Nuvation Bio had annual revenue of $62.90M with 698.96% growth. That makes Nuvation Bio the 18,688th largest company in the world by revenue and 2,988th in the United States.

• Revenue (ttm): $169.90M
• Revenue Growth: +1,083.56%
• P/S Ratio: 9.84
• Revenue / Employee: $557,049
• Employees: 305
• Market Cap: 1.67B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 28.83M 45.8%
• United States 24.66M 39.2%
• China 9.41M 15.0%

Fiscal year ended Dec 31, 2025 See the full Nuvation Bio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.90M	55.03M	698.96%
Dec 31, 2024	7.87M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error